These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23411684)

  • 21. Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude rats.
    Ning S; Tian J; Marshall DJ; Knox SJ
    Cancer Res; 2010 Oct; 70(19):7591-9. PubMed ID: 20841470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice.
    Hast J; Schiffer IB; Neugebauer B; Teichman E; Schreiber W; Brieger J; Kim DW; Gebhard S; Born CJ; Strugala M; Sagemüller J; Brenner W; Mann WJ; Oesch F; Thelen M; Hengstler JG
    Anticancer Res; 2002; 22(2A):677-88. PubMed ID: 12014637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).
    Görn M; Habermann CR; Anige M; Thöm I; Schuch G; Andritzky B; Brandl S; Burkholder I; Edler L; Hossfeld DK; Bokemeyer C; Laack E
    Onkologie; 2008 Apr; 31(4):185-9. PubMed ID: 18418020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor.
    Steiner P; Joynes C; Bassi R; Wang S; Tonra JR; Hadari YR; Hicklin DJ
    Clin Cancer Res; 2007 Mar; 13(5):1540-51. PubMed ID: 17332300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer.
    Bruns CJ; Koehl GE; Guba M; Yezhelyev M; Steinbauer M; Seeliger H; Schwend A; Hoehn A; Jauch KW; Geissler EK
    Clin Cancer Res; 2004 Mar; 10(6):2109-19. PubMed ID: 15041732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
    Schiller JH; Bittner G
    Clin Cancer Res; 1999 Dec; 5(12):4287-94. PubMed ID: 10632372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].
    Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.
    Wang R; Qin S; Chen Y; Li Y; Chen C; Wang Z; Zheng R; Wu Q
    Oncol Rep; 2012 Aug; 28(2):439-45. PubMed ID: 22641525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].
    Yuan J; Wu CW; Liu ZJ; Wei XY; Li K
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):580-5. PubMed ID: 21122408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature.
    Wang C; Zhao M; Liu YR; Luan X; Guan YY; Lu Q; Yu DH; Bai F; Chen HZ; Fang C
    Biomaterials; 2014 Jan; 35(4):1215-26. PubMed ID: 24231414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer.
    Yuan A; Yang PC; Yu CJ; Lee YC; Yao YT; Chen CL; Lee LN; Kuo SH; Luh KT
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2157-62. PubMed ID: 8520790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiangiogenic agents and chemotherapy in advanced non-small cell lung cancer: a clinical perspective.
    Girard N
    Expert Rev Anticancer Ther; 2013 Oct; 13(10):1193-206. PubMed ID: 24134421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel synergistic effect of iron depletion on antiangiogenic cancer therapy.
    Ohara T; Noma K; Urano S; Watanabe S; Nishitani S; Tomono Y; Kimura F; Kagawa S; Shirakawa Y; Fujiwara T
    Int J Cancer; 2013 Jun; 132(11):2705-13. PubMed ID: 23161652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges].
    Hirai F
    Gan To Kagaku Ryoho; 2015 Aug; 42(8):940-3. PubMed ID: 26353391
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis.
    Guan YY; Luan X; Xu JR; Liu YR; Lu Q; Wang C; Liu HJ; Gao YG; Chen HZ; Fang C
    Biomaterials; 2014 Mar; 35(9):3060-70. PubMed ID: 24393268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events.
    Kim JH; Choi DS; Lee OH; Oh SH; Lippman SM; Lee HY
    Blood; 2011 Sep; 118(9):2622-31. PubMed ID: 21551235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model.
    Masuda C; Sugimoto M; Wakita D; Monnai M; Ishimaru C; Nakamura R; Kinoshita M; Yorozu K; Kurasawa M; Kondoh O; Yamamoto K
    Clin Exp Metastasis; 2020 Feb; 37(1):199-207. PubMed ID: 31768815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.